Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Acta Ophthalmol. 2012 Aug;90(5):445-8. doi: 10.1111/j.1755-3768.2010.02085.x. Epub 2011 Jan 14.
High intraocular pressure (IOP) and glaucoma are often suspected in patients with mucopolysaccharidosis (MPS). To determine corneal hysteresis (CH) and IOP in children with mucopolysaccharidosis I-Hurler (MPS I-H) and MPS VI.
Clinical measurements with ocular response analyzer (ORA).
In seven patients, five with MPS I-H treated with stem cell transplantation (SCT), and two with MPS VI, one treated with SCT and the other with enzyme therapy, the IOP was examined with ORA. Ocular response analyzer measurements were made at a median age of 8.7 years in the patients with MPS I-H and at a median age of 9.3 years in the patients with MPS VI. Earlier measurements had raised suspicion of high IOP in one patient. The ORA showed an increased CH and a falsely high IOP values in all 14 eyes. The recalculated IOPs were normal in all 14 eyes. Mild to severe corneal opacities were present in all 14 eyes. Optic disc areas, borders and cupping were clinically normal in the 12 of 14 eyes that were possible to examine. Severe corneal opacities hampered optic disc evaluation in the older patient with MPS VI. Three eyes in two patients had normal thickness of the retinal nerve fibre layer measured with scanning laser polarimetry with corneal compensation (GDx VCC). No patient was diagnosed or treated for glaucoma.
The IOPs are often falsely high because of an increased resistance of the cornea and correlate to the extent of corneal clouding. In this small, cross-sectional study, it appears that corneal resistance is directly correlated with corneal clouding, although a longitudinal study that evaluates resistance as the cornea clears with treatment would provide more direct evidence that corneal deposits are directly related to resistance. A correct measured IOP can avoid unnecessary medical or surgical hypotensive treatment.
在黏多糖贮积症(MPS)患者中,常怀疑存在高眼压(IOP)和青光眼。本研究旨在确定黏多糖贮积症 I-Hurler 型(MPS I-H)和 MPS VI 患儿的角膜滞后(CH)和 IOP。
使用眼反应分析仪(ORA)进行临床测量。
本研究纳入了 7 名患者,其中 5 名为 MPS I-H 经干细胞移植(SCT)治疗,2 名为 MPS VI,1 名为 SCT 治疗,1 名为酶替代治疗。对这 7 名患者的 IOP 进行了 ORA 检查。MPS I-H 患者的中位年龄为 8.7 岁,MPS VI 患者的中位年龄为 9.3 岁。在其中 1 名患者中,早期的 ORA 检查结果提示可能存在高眼压。所有 14 只眼的 ORA 显示 CH 增加和假性高眼压值。所有 14 只眼的重新计算的 IOP 值均正常。所有 14 只眼均存在轻至重度角膜混浊。在可能进行检查的 12 只眼中,14 只眼的视盘面积、边界和杯盘比均为临床正常。1 名 MPS VI 年龄较大的患者因严重角膜混浊而妨碍了视盘评估。2 名患者的 3 只眼的视网膜神经纤维层厚度通过带角膜补偿的扫描激光偏振测量法(GDx VCC)测量正常。无患者被诊断或治疗青光眼。
由于角膜阻力增加,IOP 通常为假性升高,且与角膜混浊程度相关。在这项小型的横断面研究中,角膜阻力似乎与角膜混浊直接相关,尽管一项评估随着治疗角膜混浊消退时阻力的纵向研究将提供更直接的证据,表明角膜沉积物与阻力直接相关。正确测量的 IOP 可避免不必要的降压药物治疗。